Viral haemorrhagic fever

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 15, Issue 1, 2015, Pages 61-66

  Fhogartaigh, Caoimhe Nic ^a   Aarons, Emma ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Rare and Imported Pathogens Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; EBOLA VACCINE; MONOCLONAL ANTIBODY; RIBAVIRIN;

AFRICA; ANTIVIRAL THERAPY; ARTICLE; CLINICAL FEATURE; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; ECOLOGY; EPIDEMIC; FLUID RESUSCITATION; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LASSA FEVER; NONHUMAN; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); POST EXPOSURE PROPHYLAXIS; RISK ASSESSMENT; SECONDARY INFECTION; VIROLOGY; VIRUS DIAGNOSIS; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION; ANIMAL; BAT; DISEASE CARRIER; HEMORRHAGIC FEVERS, VIRAL; RUMINANT; TICK; TRANSMISSION;

ANIMALS; CHIROPTERA; DISEASE RESERVOIRS; DISEASE VECTORS; HEMORRHAGIC FEVERS, VIRAL; HUMANS; RUMINANTS; TICKS;

EID: 85003054053     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.15-1-61     Document Type: Article

References (20)

1. Brès P. The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976 (introductory note). Bull World Health Organ 1978;56:245.
2. Public Health England. Ebola and Marburg haemorrhagic fevers: outbreaks and case locations. Available online at www.gov. uk/ebolaand-marburg-haemorrhagic-fevers-outbreaks-and-case-locations [Accessed 17 November 2014].
3. Bonin O. The Cercopithecus monkey disease in Marburg and Frankfurt (Main), 1967. Acta Zool Pathol Antverp 1969;48:319-31.
4. Monath TP. Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ 1975;52:577-92.
5. Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West African sub-region: an overview. J Vector Borne Dis 2007;44:1-11.
6. Fichet-Calvet E and Rogers DJ. Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis 2009;3:e388.
7. Bente DA, Forrester NL, Watts DM et al. Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 2013;100:159-89.
8. Bannister B. Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. Br Med Bull 2010;95:193-225.
9. Feldmann H and Geisbert TW. Ebola Haemorrhagic Fever. Lancet 2011;377:849-62.
10. Bah EI, Lamah MC, Fletcher T et al. Clinical presentation of patients with ebola virus disease in Conakry, Guinea. N Engl J Med 2014, in print.
11. Mehedi M, Groseth A, Feldmann H, Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future Virol 2011;6:1091-106.
12. WHO (2014). Ebola response roadmap - Situation report update. Global Alert and Response, 17 December 2014. Available online at www.who.int/csr/disease/ebola/situation-reports/en/[Accessed 22 December 2014].
13. Rollin PE, Bausch DG, and Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007;196(Suppl 2):S364-71.
14. Towner JS, Rollin PE, Bausch DG et al. Rapid diagnosis of Ebola haemorrhagic fever by reverse-transcription PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004;78:4330-41.
15. Advisory Committee on Dangerous Pathogens. Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. November 2014. Available online at www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1194947382005 [Accessed 30 November 2014].
16. WHO. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 1978;56:247-70.
17. WHO. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978;56:271-93.
18. McCormick JB, King IJ, Webb PA et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314:20-6.
19. Ascioglu S, Leblebicioglu H, Vahaboglu H, Chan KA. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 2011;66:1215-22.
20. Qiu X, Audet J, Wong G et al. Successful treatment of ebola virusinfected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 2012;4:138.